SecBot SecBot
144 ·Filed Nov 9, 2026

NVCR

NovoCure Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 6h ago SEC0001950047-26-010825
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and likely a routine diversification move by an officer. Monitor for any subsequent Form 4 filings to confirm execution and for any pattern of larger insider sales.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$11.81
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.52%
T+1 · $11.99
Vs SPY
+0.21%
α at T+1
Next horizon
T+5
in 8h
  1. T+0 · Nov 10 $11.81entry
  2. T+1 · 6d ago +1.52%α +0.21% · $11.99
  3. T+4 · todayOpen
  4. T+5 · in 8h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Christoph Brackmann, an officer of NovoCure, filed a Form 144 notice of intent to sell 7,343 shares of common stock, with an approximate market value of $94,446 based on a filing date price. The sale represents a small fraction of the company's $1.6B market cap and is a routine insider disposition.

Key Facts

  • Reporting owner: Christoph Brackmann, an officer of NovoCure Ltd
  • Securities to be sold: 7,343 shares of common stock
  • Approximate value of shares: $94,445.67
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  • Proposed sale date: November 9, 2026
  • Shares acquired on November 4, 2026 via restricted stock from the issuer
  • Market cap of NovoCure: $1.6B

Financial Impact

Sale of 7,343 shares valued at ~$94K, representing less than 0.01% of market cap

dilution

Risk Factors

  • Insider sale intent may signal reduced conviction, though the small size limits concern
  • No information on total holdings of the officer to assess proportion sold

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
69% bullish (13 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010825
Document: 0001950047-26-010825-index.html0001950047-26-010825
Document: 0001950047-26-010825.txt0001950047-26-010825

Track record

20 reports on NVCR

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +19.75% at T+20 after the Feb 27, 2026 report. 5 of 7 went positive at some point.

Filters
  1. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $11.83 to $11.30 Now $11.30 −4.48% ▼ −4.48% −2.57% vs SPY
  2. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  3. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $11.81 to $11.99 Now $11.30 −4.32% ▲ +1.52% +0.21% vs SPY
  4. Nov 9, 20267d ago 8-K Bearish 6/10 Entry $12.53 to $11.81 Now $11.30 +9.82% ▲ +5.75% +5.38% vs SPY
  5. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $13.11 to $13.15 Now $11.30 −13.81% ▲ +0.31% +2.08% vs SPY
  6. Oct 1, 20266w ago 8-K Bullish 6/10 Entry $15.92 to $14.94 Now $11.30 −29.02% ▼ −6.16% −6.90% vs SPY
  7. Sep 9, 20269w ago 8-K Neutral 2/10 Entry $15.63 to $15.35 Now $11.30 −27.70% ▼ −1.79% −1.19% vs SPY
  8. Sep 1, 202610w ago 8-K Neutral 3/10 Entry $17.38 to $17.83 Now $11.30 −34.98% ▲ +2.59% +2.15% vs SPY
  9. Jul 23, 202616w ago 8-K Bullish 7/10 Entry $19.99 to $17.65 Now $11.30 −43.47% ▼ −11.71% −11.81% vs SPY
  10. Jun 30, 202619w ago 8-K Bullish 7/10 Entry $15.15 to $15.78 Now $11.30 −25.41% ▲ +4.16% +4.29% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens Wed (10h 24m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026